Table 1.

Demographic information.

Variable		Total a (n=717)		Without PN (n=418)		With PN (n=279)
		M	SD	M	SD	M	SD
Age (years)		72.7	12.1	73.3	12.4	71.8	11.9
Education (years)		12.7	2.9	12.7	2.9	12.8	3.1
Time since diagnosis (months)		26.8	48.2	24.8	44.4	28.3	47.6
		F	%	F	%	F	%
Gender	Male	400	55.8	225	53.8	169	60.6
	Female	311	43.4	192	45.9	110	39.4
	Missing	6	0.8	1	0.2
Race/Ethnicity	White/Caucasian	690	96.2	402	96.2	273	97.8
	African American	11	1.5	8	1.9	3	1.1
	Hispanic	7	1.0	7	1.7	0.0	0.0
	Asian	1	0.1	0	0.0	1	0.4
	Other	3	0.4	1	0.2	2	0.7
	Missing	5	0.7
Marital status	Single, divorced,separated, or widowed	258	35.9	159	38.0	95	34.0
	Married	451	62.9	256	61.2	184	65.9
	Missing	8	1.1	3	0.7
Cancer Type	Lung	241	33.6	138	33.0	100	35.8
	Pancreas	65	9.1	47	11.2	15	5.4
	Colon	51	7.1	30	7.2	21	7.5
	Prostate	42	5.9	23	5.5	16	5.7
	Breast	40	5.6	18	4.3	19	6.8
	Liver	28	3.9	14	3.3	14	5.0
	Ovarian	25	3.5	15	3.6	10	3.6
	Head & Neck	24	3.3	13	3.1	11	3.9
	Lymphoma	21	2.9	13	3.1	6	2.2
	Kidney	19	2.6	15	3.6	4	1.4
	Bladder	16	2.2	10	2.4	6	2.2
	Esophagus	15	2.1	10	2.4	5	1.8
	Brain/Nervous system	13	1.8	5	1.2	7	2.5
	Leukemia/MDS	13	1.8	11	2.6	2	0.7
	Stomach	11	1.5	4	1.0	7	2.5
	Multiple Myeloma	8	1.1	6	1.4	2	0.7
	Bone	8	1.1	2	0.5	6	2.2
	Uterine	7	1.0	5	1.2	2	0.7
	Skin	6	0.8	3	0.7	3	1.1
	Cervical	5	0.7	4	1.0	1	0.4
	Sarcoma	5	0.7	2	0.5	3	1.1
	Other	45	6.3	21	5.0	18	6.4
	Missing	9	1.3

^aincludes all individuals enrolled in the study, 20 of whom did not provide MSAS data and weren’t included in the analysis